Merrimack Pharmaceuticals Inc. sell StockNews.com
Start price
24.06.23
/
50%
€3.98
Target price
24.06.24
-
Performance (%)
-
End price
25.06.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Merrimack Pharmaceuticals Inc. | - | - | - |
iShares Core DAX® | -0.145% | -2.221% | 11.782% |
iShares Nasdaq 100 | 1.296% | 9.035% | 34.565% |
iShares Nikkei 225® | 1.282% | 3.119% | 8.953% |
iShares S&P 500 | 0.442% | 5.429% | 27.376% |
Comments by StockNews_com for this prediction
In the thread Merrimack Pharmaceuticals Inc. diskutieren
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for MACK provided by MarketBeat
In the thread Trading Merrimack Pharmaceuticals Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Merrimack Pharmaceuticals Inc.
Merrimack Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.98
08.07.23
08.07.23
-
08.07.24
08.07.24
-
30.09.21
30.09.21